Menopause
Conference Coverage
COVID-19 Pandemic stress affected ovulation, not menstruation
The ‘experiment of nature’ that coincided with the COVID-19 pandemic lockdown produced several findings that call into question commonly held...
From the Journals
Why do we treat menopause as a disease?
Over centuries society and medicine have emphasized the negative aspects, and authors of a new analysis say this has eaten away at women’s...
Conference Coverage
Nonhormonal drug for menopause symptoms passes phase 3 test
The novel NK3 receptor–inhibitor fezolinetant controlled vasomotor symptoms of menopause over 52 weeks in the phase 3 SKYLIGHT 2 trial.
Conference Coverage
Surgeons may underestimate recovery from incontinence operation
The researchers found that just over 40% of women reported returning to work and other normal activities within 2 weeks of having undergone...
Clinical Review
Knowledge gaps and challenges in care for menopausal women
The lack of discussion in society, and the lack of clinician knowledge around the menopausal transition and its overall effects for women,result...
Sponsored Supplement
Ospemifene, an oral SERM for dyspareunia of menopause: Is it being underutilized?
Latest News
Hormones account for 10% of lipid changes after menopause
“Menopause is not avoidable, but perhaps the negative metabolite shift can be diminished by lifestyle choices.”
Latest News
Transvaginal mesh, native tissue repair have similar outcomes in 3-year trial
An expert says the study is unlikely to change minds in the contentious debate over options for pelvic organ prolapse as the two sides “are deeply...
Reproductive Rounds
Unraveling primary ovarian insufficiency
Unless there is an absolute contraindication, estrogen therapy should be prescribed to women with POI to reduce the risk of osteoporosis,...
From the Journals
‘Forever chemicals’ exposures may compound diabetes risk
The increased risk of diabetes observed among women exposed to a combination of ‘forever chemicals’ is similar to that associated with overweight...
Clinical Review
SERMs revisited: Can they improve menopausal care?
While most clinicians are very familiar with older SERMS like tamoxifen and raloxifene, newer agents such as ospemifene and...
Latest News
Some reproductive factors linked with risk of dementia
An analysis of UK Biobank data finds women’s oral contraceptive use was among factors associated with a lower dementia risk.